The WT1 protein is a negative regulator of the normal bcl-2 allele in t(14;18) lymphomas

J Biol Chem. 1997 Aug 1;272(31):19609-14. doi: 10.1074/jbc.272.31.19609.

Abstract

The translocated and normal bcl-2 alleles in the DHL-4 cell line with the t(14;18) translocation were separated by pulsed field electrophoresis. An in vivo footprint over a potential WT1 binding site in the bcl-2 5'-flanking sequence was identified on the normal silent allele. Electrophoretic mobility shift assays with the bcl-2 WT1 site demonstrated a single specific complex. UV cross-linking and Western analysis revealed that this gel shift complex contained WT1 protein. Deletion or mutation of the WT1 site resulted in an increase in activity of the bcl-2 promoter in DHL-4 cells. Cotransfection with a 3:1 ratio of a WT1 expression vector to the bcl-2 promoter construct led to a 3.0-fold repression of the bcl-2 promoter. Cotransfection with a WT1 expression vector and the bcl-2 promoter with the mutated WT1 site resulted in only 1.2-fold repression. We conclude that the WT1 site functions as a negative regulatory site for the normal silent bcl-2 allele in t(14;18) lymphomas. The WT1 site is not occupied on the translocated bcl-2 allele.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Alleles*
  • Chromosomes, Human, Pair 14*
  • Chromosomes, Human, Pair 18*
  • DNA-Binding Proteins / physiology*
  • Enhancer Elements, Genetic
  • Genes, Immunoglobulin
  • Genes, bcl-2*
  • Humans
  • Lymphoma / genetics*
  • Promoter Regions, Genetic
  • Transcription Factors / physiology*
  • Translocation, Genetic*
  • Tumor Cells, Cultured
  • WT1 Proteins

Substances

  • DNA-Binding Proteins
  • Transcription Factors
  • WT1 Proteins